Literature DB >> 22546203

Novel inhibitors of heat shock protein Hsp70-mediated luciferase refolding that bind to DnaJ.

Joel A Cassel1, Sergey Ilyin, Mark E McDonnell, Allen B Reitz.   

Abstract

Inhibitors of both heat shock proteins Hsp90 and Hsp70 have been identified in assays measuring luciferase refolding containing rabbit reticulocyte lysate or purified chaperone components. Here, we report the discovery of a series of phenoxy-N-arylacetamides that disrupt Hsp70-mediated luciferase refolding by binding to DnaJ, the bacterial homolog of human Hsp40. Inhibitor characterization experiments demonstrated negative cooperativity with respect to DnaJ and luciferase concentration, but varying the concentration of ATP had no effect on potency. Thermal shift analysis suggested a direct interaction with DnaJ, but not with Hsp70. These compounds may be useful tools for studying DnaJ/Hsp40 in various cellular processes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22546203     DOI: 10.1016/j.bmc.2012.03.067

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

Review 1.  The Chemical Biology of Molecular Chaperones--Implications for Modulation of Proteostasis.

Authors:  Kristoffer R Brandvold; Richard I Morimoto
Journal:  J Mol Biol       Date:  2015-05-21       Impact factor: 5.469

2.  Inhibition of Both Hsp70 Activity and Tau Aggregation in Vitro Best Predicts Tau Lowering Activity of Small Molecules.

Authors:  Mackenzie D Martin; Jeremy D Baker; Amirthaa Suntharalingam; Bryce A Nordhues; Lindsey B Shelton; Dali Zheng; Jonathan J Sabbagh; Timothy A J Haystead; Jason E Gestwicki; Chad A Dickey
Journal:  ACS Chem Biol       Date:  2016-05-26       Impact factor: 5.100

Review 3.  Putting human Tid-1 in context: an insight into its role in the cell and in different disease states.

Authors:  Sagarika Banerjee; Rupesh Chaturvedi; Anu Singh; Hemant R Kushwaha
Journal:  Cell Commun Signal       Date:  2022-07-19       Impact factor: 7.525

Review 4.  Heat shock proteins 27, 40, and 70 as combinational and dual therapeutic cancer targets.

Authors:  Jeanette R McConnell; Shelli R McAlpine
Journal:  Bioorg Med Chem Lett       Date:  2013-02-13       Impact factor: 2.823

5.  The development of modified human Hsp70 (HSPA1A) and its production in the milk of transgenic mice.

Authors:  Yaroslav G Gurskiy; David G Garbuz; Nataliya V Soshnikova; Aleksey N Krasnov; Alexei Deikin; Vladimir F Lazarev; Dmitry Sverchinskyi; Boris A Margulis; Olga G Zatsepina; Vadim L Karpov; Svetlana N Belzhelarskaya; Evgenia Feoktistova; Sofia G Georgieva; Michael B Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2016-08-10       Impact factor: 3.667

Review 6.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

7.  Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma.

Authors:  Hui Wang; Fang Feng; Xiao-Ping Wang; Rou-Shu Wang; Ying Wu; Min-Gao Zhu; Hong Zhang; Zhi-Xiang Zhuang
Journal:  Mol Med Rep       Date:  2015-12-07       Impact factor: 2.952

Review 8.  Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.

Authors:  Marc Brehme; Cindy Voisine
Journal:  Dis Model Mech       Date:  2016-08-01       Impact factor: 5.758

9.  Inhibition of Heat Shock proteins HSP90 and HSP70 induce oxidative stress, suppressing cotton fiber development.

Authors:  Anshulika Sable; Krishan M Rai; Amit Choudhary; Vikash K Yadav; Sudhir K Agarwal; Samir V Sawant
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

10.  Sensitizing tumor cells to conventional drugs: HSP70 chaperone inhibitors, their selection and application in cancer models.

Authors:  Vladimir F Lazarev; Dmitry V Sverchinsky; Elena R Mikhaylova; Pavel I Semenyuk; Elena Y Komarova; Sergey A Niskanen; Alina D Nikotina; Anton V Burakov; Viktor G Kartsev; Irina V Guzhova; Boris A Margulis
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.